Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2010 067 678.1 |
| 96 | EP file number | EAKZ | 10 38 2153.4 |
| 97 | EP publication number | EPN | 2394663 |
| 54 | Designation/title | TI | Zusammensetzungen für injizierbare, in-situ biologisch abbaubare Implantate |
| 51 | IPC main class | ICM
(ICMV) | A61K 47/34 (2006.01) |
| 22 | DE application date | DAT | May 31, 2010 |
| 96 | EP application date | EAT | May 31, 2010 |
| 43 | Date of first publication | OT | Dec 14, 2011 |
| Date of publication of grant | PET | Oct 13, 2021 |
| 71/73 | Applicant/owner | INH | LABORATORIOS FARMACEUTICOS ROVI, S.A., Madrid, ES |
| 72 | Inventor | IN | Guierro Aduriz, Ibon, 28037 Madrid, ES; Gómez Ochoa, María Teresa, 28037 Madrid, ES |
| Address for service | | Elzaburu S.L.P., 28046 Madrid, ES |
| Due date | FT
FG | May 31, 2025
Annual fee for the 16th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002394663
Searchable text:
EP000002394663
Original document:
EP000002394663B1
Searchable text:
EP000002394663B1 |
| 43 | Date of first publication | EVT | Dec 14, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Jan 27, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | May 29, 2024
(Show all update days)(Hide all update days)- May 29, 2024; Jun 1, 2023; Nov 11, 2022; Oct 6, 2022; Sep 1, 2022; May 28, 2022; Nov 29, 2021; Oct 28, 2021; Sep 23, 2021; Jun 10, 2021; Jun 28, 2018; Dec 1, 2016; Feb 16, 2013
- Historical data not available for this/these date(s)
- Jan 27, 2012
- Date of the first transfer into DPMAregister
|
